Veterinary Drugs Market Analysis From 2020 To 2025 is latest market research study on Global Veterinary Drugs Market published by Fortune Business Insights. According to report Global Veterinary Drugs Market is expected to grow at 5.6% CAGR and to reach USD 27,570.0 Million by 2025. Market for Veterinary Drugs Industry is segmented by Product, Animal, Route of Administration, Distribution Channel and Region. Asia-Pacific Is Expected to Witness Fattest Growth in The Veterinary Drugs Market.
Report segments Veterinary Drugs Market by Product (Anti-infectives, Anti-inflammatory, Parasiticides, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others,) and Regional Forecast, 2018 – 2025
Leading Veterinary Drugs Market Companies Analyzed in Report
Bayer AG., Zoetis Animal Healthcare, Virbac S.A. Vetoquinol, Ceva, Vetoquinol S.A., Merial Animal Health, Merck Ltd., Elanco, Intervet Inc., and Boehringer Ingelheim International GmbH.
Global Veterinary Drugs Market 2019 Insights:
The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global veterinary drugs market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global veterinary drugs market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.
The parasiticides segment accounted for the highest share in 2017 with a market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.
Highlights of the Report:
- In-depth analysis of various insights, namely, Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
The rise in prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.
On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.
Nevertheless, the rising number of meat consuming people and increasing demand for animal products such as milk, ghee, cheese, and eggs are creating better growth opportunities for the veterinary drugs market.
Governments are also imposing stringent regulatory measures for improving animal safety. Such policies will not only keep animals safe from diseases but also improve the quality of products we derive from them.
Veterinary Drugs Market Regional Analysis:
The rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.
On the other side, Asia Pacific is expected to show remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in Asia Pacific.
Vendors are entering into strategic collaborations, merger and acquisitions, and new product launches in order to gain strong foothold in the market. They are also investing huge sums into research and development strategies for the discovery of new drugs to prevent various diseases from occurring in animals.
Key questions answered in the report:
- What will the market growth rate of Veterinary Drugs market in 2025?
- What are the key factors driving the global Veterinary Drugs market?
- Who are the key manufacturers in Veterinary Drugs market space?
- What are the market opportunities, market risk and market overview of the Veterinary Drugs market?
- What are sales, revenue, and price analysis of top manufacturers of Veterinary Drugs market?
- Who are the distributors, traders and dealers of Veterinary Drugs market?
- What are the Veterinary Drugs market opportunities and threats faced by the vendors in the global Veterinary Drugs industry?
- What are sales, revenue, and price analysis by types and applications of Veterinary Drugs market?
- What are sales, revenue, and price analysis by regions of Veterinary Drugs industry?
Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1 Pipeline Analysis of Veterinary Drugs
4.2 Overview of Company Share Analysis
4.3 Overview of Strategies by Key Market Leaders
4.4 Key Industry Developments such as Mergers & Acquisitions
4.5 New Product Launches
4.6 Regulatory Scenario
4.7 Overview of Cost Analysis
- Global Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.3. Market Analysis, Insights and Forecast – By Animal
5.4 Market Analysis, Insights and Forecast – By Route of Administration
5.5. Market Analysis, Insights and Forecast – By Distribution Channel
5.5.1 Veterinary Hospitals
5.5.2 Veterinary Clinics
5.5.3 Pharmacies & Drug Stores
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1 North America
5.6.3 Asia Pacific
5.6.4 Latin America
5.6.5 Middle East & Africa
- North America Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
6.1. Key Findings / Summary
6.2. Market Analysis – By Product
6.3. Market Analysis – By Animal
6.4. Market Analysis – By Route of Administration
6.5. Market Analysis – By Distribution Channel
6.5.1 Veterinary Hospitals
6.5.2 Veterinary Clinics
6.5.3 Pharmacies & Drug Stores
6.6. Market Analysis – By Country
- Europe Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
7.1. Key Findings / Summary
7.2. Market Analysis – By Product
7.3. Market Analysis – By Animal
7.4. Market Analysis – By Route of Administration
7.5. Market Analysis – By Distribution Channel
7.5.1 Veterinary Hospitals
7.5.2 Veterinary Clinics
7.5.3 Pharmacies & Drug Stores
7.6. Market Analysis – By Country/ Sub-region
7.6.7 Rest of Europe
- Asia Pacific Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
8.1. Key Findings / Summary
8.2. Market Analysis – By Product
8.3. Market Analysis – By Animal
8.4. Market Analysis – By Route of Administration
8.5. Market Analysis – By Distribution Channel
8.5.1 Veterinary Hospitals
8.5.2 Veterinary Clinics
8.5.3 Pharmacies & Drug Stores
8.6. Market Analysis – By Country/ Sub-region
8.6.5 Southeast Asia
8.6.6 Rest of Asia Pacific
- Latin America Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
9.1. Key Findings / Summary
9.2. Market Analysis – By Product
9.3. Market Analysis – By Animal
9.4. Market Analysis – By Route of Administration
9.5. Market Analysis – By Distribution Channel
9.5.1 Veterinary Hospitals
9.5.2 Veterinary Clinics
9.5.3 Pharmacies & Drug Stores
9.6. Market Analysis – By Country/Sub-region
9.6.3 Rest of Latin America
- Middle East & Africa Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025
10.1. Key Findings / Summary
10.2. Market Analysis – By Product
10.3. Market Analysis – By Animal
10.4. Market Analysis – By Route of Administration
10.5. Market Analysis – By Distribution Channel
10.5.1 Veterinary Hospitals
10.5.2 Veterinary Clinics
10.5.3 Pharmacies & Drug Stores
10.6. Market Analysis – By Country
10.6.1 South Africa
10.6.2 GCC Countries
10.6.3 Rest of Middle East & Africa
- Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2017)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.2 Intervet Inc.
11.5.3 Boehringer Ingelheim International GmbH
11.5.6 Vetoquinol S.A.
11.5.7 Bayer AG
11.5.8 Other Prominent Players
- Strategic Recommendations
Browse Complete “Veterinary Drugs Market Size, Share and Industry Analysis and Regional Forecast till 2025 Report” at: https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245